GLSIGreenwich LifeSciences, Inc.

Nasdaq greenwichlifesciences.com


$ 13.98 $ 0.40 (2.86 %)    

Friday, 03-May-2024 14:40:03 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 14.39
$ 14.30
$ 0.00 x 0
$ 0.00 x 0
$ 13.98 - $ 14.30
$ 7.58 - $ 21.44
35,468
na
184.89M
$ 0.42
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-15-2024 12-31-2023 10-K
2 10-19-2023 09-30-2023 10-Q
3 08-21-2023 06-30-2023 10-Q
4 05-22-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-15-2022 06-30-2022 10-Q
8 05-20-2022 03-31-2022 10-Q
9 03-21-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
11 08-13-2021 06-30-2021 10-Q
12 05-20-2021 03-31-2021 10-Q
13 03-31-2021 12-31-2020 10-K
14 11-16-2020 09-30-2020 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 insiders-buying-greenwich-lifesciences-and-2-other-stocks

Although U.S. stocks closed mostly lower on Friday, there were a few notable insider trades.

 hc-wainwright--co-reiterates-buy-on-greenwich-lifesciences-maintains-36-price-target

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $36 price t...

 greenwich-lifesciences-flamingo-01-phase-3-trial-which-is-evaluating-glsi-100-an-immunotherapy-to-prevent-breast-cancer-recurrences-approved-to-expand-into-five-largest-european-countries

The Company's application to expand Flamingo-01 into Europe has been formally approved by Spain, France, Germany, Italy, an...

 greenwich-lifesciences-flamingo-01-manufacturing--protocol-accepted-by-european-regulators

The Company was informed that the manufacturing, non-clinical, clinical, statistical, and regulatory sections of its applicatio...

 hc-wainwright--co-maintains-buy-on-greenwich-lifesciences-lowers-price-target-to-36

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price targe...

 why-greenwich-lifesciences-glsi-stock-is-skyrocketing

Greenwich Lifesciences shares are trading higher by 30.6% Wednesday afternoon. The company provided an update on the Phase III ...

 stocks-that-hit-52-week-lows-on-monday

  On Monday, 369 companies set new 52-week lows.

 hc-wainwright--co-reiterates-buy-on-greenwich-lifesciences-lowers-price-target-to-38

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and lowers the price targ...

 47m-bet-on-tillys-check-out-these-3-stocks-insiders-are-buying

Although US stocks closed higher on Tuesday, there were a few notable insider trades.

 why-coupa-software-shares-jumped-around-29-here-are-72-biggest-movers-from-wednesday

Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesda...

 bitcoin-holder-microstrategy-and-4-more-short-squeeze-stocks-that-could-soar-this-week

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge move.

 virgin-orbit-and-4-more-short-squeeze-stocks-that-could-soar-this-week--including-a-stock-moving-up-968-positions

Potential short squeeze plays gained steam in 2021 and has continued through 2022 with new traders looking for the next huge mo...

 top-ships-weber-and-3-more-short-squeeze-stocks-that-could-soar-this-week

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge m...

 grenwich-lilfesciences-blue-apron-and-3-more-short-squeeze-candidates-that-may-soar

Potential short squeeze plays gained steam in 2021 and have continued through 2022 with new traders looking for the next huge m...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION